These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38155969)

  • 1. Complement C1q and von Willebrand factor interaction in atherosclerosis of human carotid artery.
    Schulz K; Donat C; Punjabi M; Glatz K; Kaufmann B; Trendelenburg M
    Front Immunol; 2023; 14():1265387. PubMed ID: 38155969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages.
    Donat C; Thanei S; Trendelenburg M
    Front Immunol; 2019; 10():2712. PubMed ID: 31824501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand Factor Interacts with Surface-Bound C1q and Induces Platelet Rolling.
    Kölm R; Schaller M; Roumenina LT; Niemiec I; Kremer Hovinga JA; Khanicheh E; Kaufmann BA; Hopfer H; Trendelenburg M
    J Immunol; 2016 Nov; 197(9):3669-3679. PubMed ID: 27698012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement C1q Enhances Primary Hemostasis.
    Donat C; Kölm R; Csorba K; Tuncer E; Tsakiris DA; Trendelenburg M
    Front Immunol; 2020; 11():1522. PubMed ID: 32765527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells in the arterial wall express C1q: potential significance in atherogenesis.
    Cao W; Bobryshev YV; Lord RS; Oakley RE; Lee SH; Lu J
    Cardiovasc Res; 2003 Oct; 60(1):175-86. PubMed ID: 14522421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of Von Willebrand Factor with carotid artery and aortic arch calcification in ischemic stroke patients.
    Sonneveld MA; van Dijk AC; van den Herik EG; van Loon JE; de Lau LM; van der Lugt A; Koudstaal PJ; de Maat MP; Leebeek FW
    Atherosclerosis; 2013 Oct; 230(2):210-5. PubMed ID: 24075746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The VWF/LRP4/αVβ3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells.
    Lagrange J; Worou ME; Michel JB; Raoul A; Didelot M; Muczynski V; Legendre P; Plénat F; Gauchotte G; Lourenco-Rodrigues MD; Christophe OD; Lenting PJ; Lacolley P; Denis CV; Regnault V
    Cardiovasc Res; 2022 Jan; 118(2):622-637. PubMed ID: 33576766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.
    Niyonzima N; Bakke SS; Gregersen I; Holm S; Sandanger Ø; Orrem HL; Sporsheim B; Ryan L; Kong XY; Dahl TB; Skjelland M; Sørensen KK; Rokstad AM; Yndestad A; Latz E; Gullestad L; Andersen GØ; Damås JK; Aukrust P; Mollnes TE; Halvorsen B; Espevik T
    EBioMedicine; 2020 Oct; 60():102985. PubMed ID: 32927275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Doddapattar P; Dhanesha N; Chorawala MR; Tinsman C; Jain M; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):520-528. PubMed ID: 29348121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intimal deposition of functional von Willebrand factor in atherogenesis.
    De Meyer GR; Hoylaerts MF; Kockx MM; Yamamoto H; Herman AG; Bult H
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2524-34. PubMed ID: 10521383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies.
    Qin F; Impeduglia T; Schaffer P; Dardik H
    J Vasc Surg; 2003 Feb; 37(2):433-9. PubMed ID: 12563218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced high shear platelet adhesion to the vascular media: defective von Willebrand factor binding to the interstitial collagen.
    Komorowic E; McBane RD; Charlesworth J; Fass DN
    Thromb Haemost; 2002 Apr; 87(4):763-70. PubMed ID: 12013023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype.
    McCarty OJ; Conley RB; Shentu W; Tormoen GW; Zha D; Xie A; Qi Y; Zhao Y; Carr C; Belcik T; Keene DR; de Groot PG; Lindner JR
    JACC Cardiovasc Imaging; 2010 Sep; 3(9):947-55. PubMed ID: 20846630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis and Low Cardiovascular Risk: The Role of von Willebrand Factor Activity.
    Ristić GG; Subota V; Lepić T; Stanisavljević D; Glišić B; Ristić AD; Petronijević M; Stefanović DZ
    PLoS One; 2015; 10(8):e0130462. PubMed ID: 26247590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand factor regulates complement on endothelial cells.
    Noone DG; Riedl M; Pluthero FG; Bowman ML; Liszewski MK; Lu L; Quan Y; Balgobin S; Schneppenheim R; Schneppenheim S; Budde U; James P; Atkinson JP; Palaniyar N; Kahr WH; Licht C
    Kidney Int; 2016 Jul; 90(1):123-34. PubMed ID: 27236750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor.
    Bergamaschini L; Mannucci PM; Federici AB; Coppola R; Guzzoni S; Agostoni A
    J Lab Clin Med; 1995 Mar; 125(3):348-55. PubMed ID: 7897302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors.
    Daza L; Aguirre M; Jimenez M; Herrera R; Bollain JJ
    Clin Rheumatol; 2007 Apr; 26(4):533-7. PubMed ID: 16758372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redistribution of von Willebrand factor in porcine carotid arteries after balloon angioplasty.
    Giddings JC; Banning AP; Ralis H; Lewis MJ
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1872-8. PubMed ID: 9351348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients.
    Srámek A; Bucciarelli P; Federici AB; Mannucci PM; De Rosa V; Castaman G; Morfini M; Mazzucconi MG; Rocino A; Schiavoni M; Scaraggi FA; Reiber JH; Rosendaal FR
    Circulation; 2004 Feb; 109(6):740-4. PubMed ID: 14970109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of enhanced expression of classical complement C1q in atherosclerosis progression and plaque instability: C1q as an indicator of clinical outcome.
    Sasaki S; Nishihira K; Yamashita A; Fujii T; Onoue K; Saito Y; Hatakeyama K; Shibata Y; Asada Y; Ohbayashi C
    PLoS One; 2022; 17(1):e0262413. PubMed ID: 35085285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.